{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:58:43Z","timestamp":1790769523529,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"DOI":"10.1007\/s00066-026-02611-3","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:18:58Z","timestamp":1790767138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of late genitourinary toxicity after definitive radiotherapy with or without intraprostatic simultaneous integrated boost in patients with prior transurethral resection of the prostate"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2742-9021","authenticated-orcid":false,"given":"Cem","family":"Onal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurcan","family":"Erbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysenur","family":"Elmali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isa Gokturk","family":"Balci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birhan","family":"Demirhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozan Cem","family":"Guler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"20","key":"2611_CR1","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1002\/cncr.34407","volume":"128","author":"M Hilscher","year":"2022","unstructured":"Hilscher\u00a0M, R\u00f8der\u00a0A, Helgstrand\u00a0JT, Klemann\u00a0N, Brasso\u00a0K, Vickers\u00a0AJ et\u00a0al (2022) Risk of prostate cancer and death after benign transurethral resection of the prostate\u2011A 20-year population-based analysis. Cancer 128(20):3674\u20133680","journal-title":"Cancer"},{"issue":"5","key":"2611_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/JU.0000000000004159","volume":"212","author":"R Leni","year":"2024","unstructured":"Leni\u00a0R, Vickers\u00a0AJ, Brasso\u00a0K, Montorsi\u00a0F, Briganti\u00a0A, Nielsen\u00a0TK et\u00a0al (2024) Management and Oncologic Outcomes of Incidental Prostate Cancer After Transurethral Resection of the Prostate in Denmark. J\u00a0Urol 212(5):692\u2013700","journal-title":"J Urol"},{"issue":"9","key":"2611_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/iju.12460","volume":"21","author":"M Pinkawa","year":"2014","unstructured":"Pinkawa\u00a0M, Klotz\u00a0J, Djukic\u00a0V, Petz\u00a0D, Holy\u00a0R, Eble\u00a0MJ (2014) Transurethral resection of the prostate after radiotherapy for prostate cancer: impact on quality of life. Int J Urol 21(9):899\u2013903","journal-title":"Int J Urol"},{"issue":"3","key":"2611_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/COC.0b013e3182546821","volume":"37","author":"H Ishiyama","year":"2014","unstructured":"Ishiyama\u00a0H, Hirayama\u00a0T, Jhaveri\u00a0P, Satoh\u00a0T, Paulino\u00a0AC, Xu\u00a0B et\u00a0al (2014) Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review. Am J Clin Oncol 37(3):297\u2013304","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"2611_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1470-2045(14)70040-3","volume":"15","author":"DP Dearnaley","year":"2014","unstructured":"Dearnaley\u00a0DP, Jovic\u00a0G, Syndikus\u00a0I, Khoo\u00a0V, Cowan\u00a0RA, Graham\u00a0JD et\u00a0al (2014) Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial. Lancet Oncol 15(4):464\u2013473","journal-title":"Lancet Oncol"},{"issue":"6","key":"2611_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0039","volume":"4","author":"JM Michalski","year":"2018","unstructured":"Michalski\u00a0JM, Moughan\u00a0J, Purdy\u00a0J, Bosch\u00a0W, Bruner\u00a0DW, Bahary\u00a0JP et\u00a0al (2018) Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial. JAMA Oncol 4(6):e180039","journal-title":"JAMA Oncol"},{"issue":"7","key":"2611_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1200\/JCO.20.02873","volume":"39","author":"LGW Kerkmeijer","year":"2021","unstructured":"Kerkmeijer\u00a0LGW, Groen\u00a0VH, Pos\u00a0FJ, Haustermans\u00a0K, Monninkhof\u00a0EM, Smeenk\u00a0RJ et\u00a0al (2021) Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial. J\u00a0Clin Oncol 39(7):787\u2013796","journal-title":"J Clin Oncol"},{"issue":"12","key":"2611_CR8","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/pros.24558","volume":"83","author":"C Onal","year":"2023","unstructured":"Onal\u00a0C, Erbay\u00a0G, Guler\u00a0OC, Yavas\u00a0C, Oymak\u00a0E (2023) Treatment outcomes of simultaneous integrated boost to intraprostatic lesions with external beam radiotherapy in localized prostate cancer patients. Prostate 83(12):1158\u20131166","journal-title":"Prostate"},{"key":"2611_CR9","doi-asserted-by":"crossref","unstructured":"Elmali A, Demirhan B, Guler OC, Onal C. Does transurethral resection of prostate increase toxicity risk after simultaneous integrated boost radiotherapy? A\u00a0matched cohort study with long-term follow-up. Strahlenther Onkol. 2025.","DOI":"10.1007\/s00066-025-02487-9"},{"issue":"9","key":"2611_CR10","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1016\/j.clon.2022.05.021","volume":"34","author":"C Huck","year":"2022","unstructured":"Huck\u00a0C, Achard\u00a0V, Zilli\u00a0T (2022) Surgical Treatments of Benign Prostatic Hyperplasia and Prostate Cancer Stereotactic Radiotherapy: Impact on Long-Term Genitourinary Toxicity. Clin Oncol (R\u00a0Coll Radiol) 34(9):e392\u2013e399","journal-title":"Clin Oncol (R\u00a0Coll Radiol)"},{"issue":"4","key":"2611_CR11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.ijrobp.2024.06.003","volume":"120","author":"M Singh","year":"2024","unstructured":"Singh\u00a0M, Maitre\u00a0P, Krishnan\u00a0A, Adsul\u00a0K, Chauhan\u00a0MS, Chauhan\u00a0H et\u00a0al (2024) Late Urinary Toxicity After Extreme or Moderate Hypofractionated Prostate Radiation Therapy in Patients With Prior Transurethral Resection of Prostate. Int J Radiat Oncol Biol Phys 120(4):1011\u20131020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2611_CR12","volume":"46","author":"M Galienne","year":"2024","unstructured":"Galienne\u00a0M, Risbourg\u00a0S, Lacornerie\u00a0T, Taillez\u00a0A, Lartigau\u00a0E, Barthoulot\u00a0M et\u00a0al (2024) Extreme hypofractionated stereotactic radiotherapy for localized prostate Cancer: Efficacy and late urinary toxicity according to transurethral resection of the prostate history. Clin Transl Radiat Oncol 46:100779","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1034","key":"2611_CR13","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20130617","volume":"87","author":"C Onal","year":"2014","unstructured":"Onal\u00a0C, Sonmez\u00a0S, Erbay\u00a0G, Guler\u00a0OC, Arslan\u00a0G (2014) Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy. Br J Radiol 87(1034):20130617","journal-title":"Br J Radiol"},{"issue":"8","key":"2611_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/pros.24693","volume":"84","author":"C Onal","year":"2024","unstructured":"Onal\u00a0C, Guler\u00a0OC, Erbay\u00a0G, Elmali\u00a0A (2024) The effect of dose-escalation radiotherapy with simultaneous-integrated-boost on the use of short-term androgen deprivation therapy in patients with intermediate risk prostate cancer. Prostate 84(8):763\u2013771","journal-title":"Prostate"},{"key":"2611_CR15","doi-asserted-by":"crossref","unstructured":"Onal C, Guler OC, Erbay G, Demirhan B, Elmali A, Yavuz M. Propensity Score Matched Analysis of External Beam Radiotherapy With or Without Focal Boost to Intraprostatic Lesions in Prostate Cancer. Prostate. 2025.","DOI":"10.2139\/ssrn.4750590"},{"key":"2611_CR16","doi-asserted-by":"crossref","unstructured":"Di Muzio NG, Deantoni CL, Brombin C, Fiorino C, Cozzarini C, Zerbetto F, et\u00a0al. Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate\u2011, High-, and Very High-Risk Prostate Cancer. Cancers (Basel). 2021;13(19).","DOI":"10.3390\/cancers13194970"},{"issue":"2","key":"2611_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s00066-009-1970-3","volume":"185","author":"G Goldner","year":"2009","unstructured":"Goldner\u00a0G, Bombosch\u00a0V, Geinitz\u00a0H, Becker\u00a0G, Wachter\u00a0S, Glocker\u00a0S et\u00a0al (2009) Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70\u00a0to 74\u202fGy. First report on 5\u2011year morbidity and biochemical control from a\u00a0prospective Austrian-German multicenter phase\u00a0II trial. Strahlenther Onkol 185(2):94\u2013100","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"2611_CR18","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.ijrobp.2007.11.066","volume":"71","author":"MJ Zelefsky","year":"2008","unstructured":"Zelefsky\u00a0MJ, Yamada\u00a0Y, Fuks\u00a0Z, Zhang\u00a0Z, Hunt\u00a0M, Cahlon\u00a0O et\u00a0al (2008) Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 71(4):1028\u20131033","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"2611_CR19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.clon.2017.03.006","volume":"29","author":"K Byrne","year":"2017","unstructured":"Byrne\u00a0K, Hruby\u00a0G, Kneebone\u00a0A, Whalley\u00a0D, Guo\u00a0L, McCloud\u00a0P et\u00a0al (2017) Late Genitourinary Toxicity Outcomes in 300 Prostate Cancer Patients Treated With Dose-escalated Image-guided Intensity-modulated Radiotherapy. Clin Oncol (R Coll Radiol) 29(9):617\u2013625","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"10","key":"2611_CR20","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00345-022-04124-x","volume":"40","author":"RV David","year":"2022","unstructured":"David\u00a0RV, Kahokehr\u00a0AA, Lee\u00a0J, Watson\u00a0DI, Leung\u00a0J, O\u2019Callaghan ME (2022) Incidence of genitourinary complications following radiation therapy for localised prostate cancer. World J Urol 40(10):2411\u20132422","journal-title":"World J Urol"},{"issue":"1","key":"2611_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.radonc.2017.12.022","volume":"127","author":"EM Monninkhof","year":"2018","unstructured":"Monninkhof\u00a0EM, van Loon\u00a0JWL, van Vulpen\u00a0M, Kerkmeijer\u00a0LGW, Pos\u00a0FJ, Haustermans\u00a0K et\u00a0al (2018) Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial. Radiother Oncol 127(1):74\u201380","journal-title":"Radiother Oncol"},{"issue":"9","key":"2611_CR22","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/0360-3016(86)90283-X","volume":"12","author":"CH Seymore","year":"1986","unstructured":"Seymore\u00a0CH, el-Mahdi\u00a0AM, Schellhammer\u00a0PF (1986) The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures. Int J Radiat Oncol Biol Phys 12(9):1597\u20131600","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2611_CR23","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.ijrobp.2009.06.078","volume":"77","author":"K Devisetty","year":"2010","unstructured":"Devisetty\u00a0K, Zorn\u00a0KC, Katz\u00a0MH, Jani\u00a0AB, Liauw\u00a0SL (2010) External beam radiation therapy after transurethral resection of the prostate: a\u00a0report on acute and late genitourinary toxicity. Int J Radiat Oncol Biol Phys 77(4):1060\u20131065","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2611_CR24","volume":"45","author":"C Huck","year":"2024","unstructured":"Huck\u00a0C, Achard\u00a0V, Maitre\u00a0P, Murthy\u00a0V, Zilli\u00a0T (2024) Stereotactic body radiation therapy for prostate cancer after surgical treatment of prostatic obstruction: Impact on urinary morbidity and mitigation strategies. Clin Transl Radiat Oncol 45:100709","journal-title":"Clin Transl Radiat Oncol"},{"key":"2611_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00555","volume":"10","author":"A Pepin","year":"2020","unstructured":"Pepin\u00a0A, Aghdam\u00a0N, Shah\u00a0S, Kataria\u00a0S, Tsou\u00a0H Jr., Datta\u00a0S et\u00a0al (2020) Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP). Front Oncol 10:555","journal-title":"Front Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02611-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-026-02611-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02611-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:19:00Z","timestamp":1790767140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-026-02611-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":25,"alternative-id":["2611"],"URL":"https:\/\/doi.org\/10.1007\/s00066-026-02611-3","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.\u00a0Onal, G.\u00a0Erbay, A.\u00a0Elmali, I.G.\u00a0Balci, B.\u00a0Demirhan and O.C.\u00a0Guler declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}